The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...

(Reuters) -The U.S. House Judiciary Committee on Monday subpoenaed a former Pfizer executive after he declined to voluntarily ...

Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my ...

Shares of Pfizer offer a yield above 7% at recent prices. Pfizer is a pharmaceutical giant that has raised its dividend every ...

A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that there was a conspiracy among ...

PFE's robust late-stage pipeline, recent FDA wins and deep oncology bets position it for long-term growth through 2030.

European Commission President Ursula von der Leyen faces a rare no-confidence vote in the European Parliament this week.

The Justice Department changed its policy on foreign corruption cases, which might have put an end to investigations into the ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

House Judiciary Chair Jim Jordan subpoenaed Dr. Philip Dormitzer after he refused to testify in the 2020 vaccine delay probe, ...

The partnership will give Chugai access to Gero’s artificial intelligence technology to discover novel targets in ...

Pfizer's hemophilia therapy, Hympavzi, met the main goal of a late-stage study in patients with certain types of antibodies, ...